Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE: 002422)
Health Care · Pharmaceuticals · CN
CN¥40.85
+5.12% today · +13.3% 1Y
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE: 002422) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.69B and employs 20,127 people.
Over the last twelve months the share price has gained 13.3%, trading between 28.14 and 52.78.
Tweenvest scores Sichuan Kelun Pharmaceutical Co., Ltd. across four factors: quality 77/100, value 17/100, growth 50/100, dividend 69/100. Its strongest factor is quality.
002422 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.69B
- Revenue (TTM)
- $2.69B
- P/E
- 35.53
- EPS
- 1.15
- Dividend yield
- 1.45%
- Beta (5Y)
- -0.20
- 52-week high
- CN¥52.78
- 52-week low
- CN¥28.14
- Avg volume (3M)
- —
- Shares outstanding
- 1.59B
- Employees
- 20,127
- Next earnings
- —
About Sichuan Kelun Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
- ISIN
- CNE100000PW7
- Founded
- 1996
- Listed since
- Jun 3, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Haisco Pharmaceutical Group Co., Ltd.SZSE: 002653 | $10.28B | CN¥62.18 | +1.42% |
| Aurobindo Pharma LimitedNSEI: AUROPHARMA | $10.02B | Rs1,676.80 | -2.06% |
| Asymchem Laboratories (Tianjin) Co., Ltd.SZSE: 002821 | $9.93B | CN¥188.62 | +5.79% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $9.80B | CN¥47.19 | +6.89% |
| Lupin LimitedBSE: 500257 | $9.64B | Rs2,029.00 | -2.92% |
| Axsome Therapeutics, Inc.NasdaqGM: AXSM | $9.06B | $170.08 | -1.67% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.SHSE: 600196 | $8.79B | CN¥24.02 | +5.17% |
| Krka, d. d.LJSE: KRKG | $8.73B | €257.50 | -0.19% |
Figures last refreshed Oct 4, 2026.